LncRNA-TIM3 exacerbates CD8+ T-cell exhaustion to compromise antitumor immunity by binding to TIM3, and repression of lncRNA-NEAT1 amplifies the anticancer effect of CD8+ T-cells against HCC via the miR-155/Tim-3 axis. The gene discussed is HAVCR2; the disease is hepatocellular carcinoma.